Akin Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-07-2024
- Paid Up Capital ₹ 0.40 M
as on 03-07-2024
- Company Age 49 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.28 Cr
as on 03-07-2024
- Satisfied Charges ₹ 1.15 Cr
as on 03-07-2024
- Revenue 14.99%
(FY 2023)
- Profit 703.57%
(FY 2023)
- Ebitda 124.96%
(FY 2023)
- Net Worth 48.38%
(FY 2023)
- Total Assets -2.56%
(FY 2023)
About Akin Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹2.28 Cr. The company has closed loans amounting to ₹1.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kartik Akinepally, Mamidi Venugopal, and Arun Akinepally serve as directors at the Company.
- CIN/LLPIN
U85101TG1975PTC001925
- Company No.
001925
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 1975
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Akin Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Akinepally  | Managing Director | 29-Sep-1981 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kartik Akinepally | Whole-Time Director | 12-Oct-2018 | Current |
| Mamidi Venugopal | Whole-Time Director | 15-Jun-2007 | Current |
Financial Performance of Akin Laboratories.
Akin Laboratories Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 14.99% increase. The company also saw a substantial improvement in profitability, with a 703.57% increase in profit. The company's net worth Soared by an impressive increase of 48.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akin Laboratories?
In 2023, Akin Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Dec 2022 | ₹1.05 M | Open |
Hdfc Bank Limited Creation Date: 13 Mar 2018 | ₹3.50 M | Open |
Andhra Bank Creation Date: 29 Jan 1991 | ₹8.10 M | Open |
How Many Employees Work at Akin Laboratories?
Akin Laboratories has a workforce of 22 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akin Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akin Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
